What elements should be included in the history of present illness (HPI) for a patient with systemic lupus erythematosus (SLE) seen in a rheumatology clinic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

History of Present Illness Elements for SLE Rheumatology Clinic Visits

At every rheumatology visit for SLE patients, the HPI must systematically assess disease activity using a validated index, quality of life through patient history or a 0-10 visual analog scale, current comorbidities, and medication toxicity 1.

Core Disease Activity Assessment (Required at Each Visit)

The HPI should capture organ-specific symptoms across all potentially affected systems:

Musculoskeletal Manifestations

  • Joint pain and swelling - location, duration, morning stiffness, functional impact
  • Myalgia - severity and distribution (reported by 76% of patients as an early symptom) 2

Mucocutaneous Symptoms

  • Photosensitivity - recent sun exposure, new rashes (79% report this early) 2
  • Malar or discoid rash changes
  • Oral or nasal ulcers
  • Alopecia - pattern and severity

Constitutional Symptoms

  • Fever - particularly important as 54% of patients report this as an early symptom, though often overlooked 2
  • Fatigue - severity on 0-10 scale (89% report as early symptom) 2
  • Weight changes

Renal Symptoms

  • New edema
  • Changes in urine output or appearance
  • Foamy urine suggesting proteinuria

Cardiopulmonary

  • Chest pain (pleuritic vs. pericardial)
  • Dyspnea
  • Palpitations

Neuropsychiatric

  • Headaches - pattern and severity
  • Cognitive changes or "brain fog"
  • Mood changes
  • Seizures or focal neurologic symptoms

Hematologic

  • Easy bruising or bleeding
  • New petechiae

Quality of Life Assessment (Required at Each Visit)

Document patient global assessment using either narrative history or a 0-10 VAS score 1. This captures:

  • Functional limitations in daily activities
  • Impact on work/school
  • Social participation
  • Sleep quality

Cardiovascular Risk Factor Review (Annually, More Frequently if on Glucocorticoids)

The HPI should document 1:

  • Smoking status - current use and pack-years
  • Physical activity level - frequency and type
  • Vascular events - any cerebrovascular or cardiovascular events since last visit
  • Hormonal therapies - oral contraceptives, hormone replacement
  • Family history - cardiovascular disease in first-degree relatives

Comorbidity Screening

Infection Risk Assessment (At Each Visit)

Document 1:

  • Recent infections - type, severity, treatment required
  • Vaccination status - particularly influenza and pneumococcal
  • Symptoms suggesting opportunistic infections if on immunosuppression

Osteoporosis Risk (Annually)

  • Calcium and vitamin D intake - dietary and supplemental 1
  • Exercise habits
  • Steroid exposure duration and cumulative dose

Metabolic Screening (Annually, More Frequently on Glucocorticoids)

  • Symptoms of hyperglycemia
  • Weight gain patterns

Medication Review (Required at Each Visit)

Systematically assess drug toxicity 1:

Hydroxychloroquine

  • Visual changes or eye symptoms (annual ophthalmology required)
  • Gastrointestinal symptoms

Glucocorticoids

  • Cushingoid features
  • Mood changes
  • Hyperglycemia symptoms
  • Bone pain

Immunosuppressants

  • Nausea, vomiting, diarrhea
  • Cytopenias symptoms (easy bruising, infections)
  • Hepatotoxicity symptoms

Adherence Assessment

  • Missed doses frequency
  • Barriers to adherence (cost, side effects, complexity)

Organ Damage Assessment (Annually)

While not strictly HPI, document any new irreversible damage since last assessment 1:

  • Cataracts
  • Avascular necrosis
  • Chronic kidney disease progression
  • Cardiovascular events
  • Cognitive impairment

Common Pitfalls to Avoid

  1. Don't overlook fever - Over half of SLE patients report fever as an early symptom, yet it's frequently dismissed 2

  2. Don't skip the patient global score - This validated outcome measure is specifically recommended at each visit and captures aspects physicians may miss 1

  3. Don't forget gastrointestinal symptoms - Though not in traditional criteria, a significant number of patients report GI complaints 2

  4. Don't assess cardiovascular risk factors only at baseline - These require at least annual reassessment, more frequently in patients on glucocorticoids 1

  5. Distinguish disease activity from damage - Active inflammation is reversible and requires treatment intensification; damage is permanent and requires prevention strategies 3

The EULAR recommendations emphasize that this structured approach decreases unwanted variability in clinical practice and improves quality of care 1. While these guidelines are from 2010, they remain the most comprehensive evidence-based framework for systematic SLE monitoring, with high agreement scores (93-98%) among expert panels 1.

References

Related Questions

What is the recommended follow‑up schedule and monitoring for a patient with systemic lupus erythematosus (SLE) based on disease activity, organ involvement, and current therapy?
What is the recommended clinical guide for diagnosing and treating systemic lupus erythematosus?
What is the appropriate management of a mild-to-moderate systemic lupus erythematosus flare in a primary care (family practice) setting?
What components should be included in the physical examination of a patient with systemic lupus erythematosus (SLE) to assess typical organ system involvement?
Which specialists should be consulted for a patient with suspected systemic lupus erythematosus presenting with cutaneous lesions?
What is the recommended first‑line antibiotic for an acute chronic obstructive pulmonary disease (COPD) exacerbation with purulent sputum in a patient without beta‑lactam contraindications?
Is an RBC copper level of 85.8 within the normal range?
Can you explain the CT abdomen and pelvis findings of nodular liver suggestive of cirrhosis, inflammatory changes at the splenic flexure consistent with focal colitis, a right renal cyst, bilateral non‑obstructing renal calculi, and multilevel degenerative spinal changes, and advise on appropriate management?
Is the outlined management plan appropriate for a patient with unspecified chest pain, type 2 diabetes mellitus, mixed hyperlipidemia, nicotine dependence, shortness of breath, and obstructive sleep apnea?
What are the differential diagnoses for a postpartum woman (2 months postpartum) presenting with generalized itching (pruritus) and numbness?
What is the recommended follow‑up schedule and monitoring for a patient with systemic lupus erythematosus (SLE) based on disease activity, organ involvement, and current therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.